跳至主要内容
临床试验/NCT02708030
NCT02708030Unknown不适用

Efficacy of Ketogenic Diet, Modified Atkins Diet and Low Glycemic Index Therapy Diet Among Children With Drug Resistant Epilepsy: A Randomised Non-Inferiority Trial

All India Institute of Medical Sciences1 个研究点 分布在 1 个国家目标入组 165 人开始时间: 2016年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
165
试验地点
1
主要终点
Percentage change in seizure frequency after 24 weeks of dietary therapy as compared to baseline, in the arm KD as compared to MAD and in the arm KD as compared to LGIT

研究概览

简要总结

This randomised trial is undertaken to assess whether MAD or LGIT is non-inferior to KD with regard to seizure control at twenty-four weeks among children with drug resistant epilepsy. The hypothesis of the study is that in 1 to 15-year-old children with drug resistant epilepsy, use of Modified Atkins Diet (MAD) or Low Glycemic Index Therapy (LGIT) as an add on to the ongoing anti-epileptic drugs would not be inferior to ketogenic diet by >15% in terms of seizure reduction from baseline seizure frequency at 24 weeks.

The primary outcome of the study is to determine the efficacy of MAD as compared to KD and LGIT as compared to KD for seizure reduction in drug resistant epilepsy following 24 weeks of dietary therapy in 1 to 15-year-old children on anti-epileptic drugs. The change in seizure frequency will be estimated as percentage change in seizure reduction at 24 weeks as compared to baseline.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Year 至 15 Years(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Children aged 1-15 years with drug resistant epilepsy (Drug resistant epilepsy for the study will be defined as seizure frequency >4 seizures per month, and treatment failure of ≥2 prescribed antiepileptic drugs).
  • •Willing to come for regular follow up

排除标准

  • •Surgically remediable cause for drug resistant epilepsy
  • •Proven inborn error of metabolism except those in which KD is indicated (i.e., Pyruvate Carboxylase deficiency and GLUT-1 Deficiency)
  • •Previously received KD, MAD or LGIT
  • •Known case of
  • •Chronic kidney disease
  • •Chronic liver disease/ GI illness
  • •Chronic heart disease (congenital and acquired)
  • •Chronic respiratory illness

研究组 & 干预措施

Ketogenic Diet

Active Comparator

Ketogenic diet (KD) will be administered by the non-fasting protocol. The child will be admitted to the hospital, and KD will be started in 1:1 ratio. The ratio will increased every 48hours to a maximum of 4:1 or ketosis (urinary ketones 40-80mg/dL) is attained. The child will thereafter be discharged and followed up on Out patient basis.

干预措施: Ketogenic Diet (Other)

Modified Atkins Diet

Experimental

Modified Atkins Diet (MAD) will be administered on out patient basis. Parents of children will be advised to monitor for seizure frequency and ketosis at home.

干预措施: MAD (Other)

Low Glycemic Index Therapy

Experimental

Low Glycemic Index Therapy (LGIT) will be administered on out patient basis. Parents of children will be advised to monitor for seizure frequency and ketosis at home.

干预措施: LGIT (Other)

结局指标

主要结局

Percentage change in seizure frequency after 24 weeks of dietary therapy as compared to baseline, in the arm KD as compared to MAD and in the arm KD as compared to LGIT

时间窗: Baseline and six months

Percentage change in seizure frequency will be estimated as mean number of weekly seizures over preceding 4 weeks after 24 weeks of dietary therapy divided by mean number of weekly seizures over preceding 4 weeks at the baseline. It will be calculated for each of the three arms (KD; MAD; LGIT) and KD will compared to MAD and LGIT individually as the primary outcome.

次要结局

  • Estimate behavior change as measured by Childhood behavior checklist in each of three arms at baseline, 12 weeks and 24 weeks after dietary therapy(Baseline, twelve weeks, and twenty-four weeks)
  • Evaluate change in serum levels of micronutrients by laboratory testing in each of three arms at baseline and six months after therapy(Baseline and twenty-four weeks)
  • Evaluate omega3 polyunsaturated fatty acid levels and correlate it with change in seizure frequency(Baseline and twenty-four weeks)
  • Proportion of patients who achieve >50% seizure reduction from baseline at 24 weeks after diet initiation(Baseline and twenty-four weeks)
  • Evaluate GI adverse events (diarrhoea, constipation and vomiting) assessed by parental questionnaire in each of the three arms at baseline and six months after therapy(Baseline and twenty-four weeks)
  • Percentage change in seizure frequency after 24 weeks of dietary therapy as compared to baseline, in the arm MAD as compared to LGIT(Baseline and twenty-four weeks)
  • Estimate cognition change as assessed by Vineland Social Maturity Scale in each of three arms at baseline, 12 weeks and 24 weeks after dietary therapy(Baseline and twenty-four weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sheffali Gulati

Professor

All India Institute of Medical Sciences

研究点 (1)

Loading locations...

相似试验

Dietary Therapy In Epilepsy Treatment (DIET-Trial):... | 临床试验